PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3587377-1	1987	The triazolodiazepines brotizolam, triazolam and alprazolam inhibited PAF-induced human platelet aggregation in vitro (IC50 = 0.54, 7.6 and 13.7 microM, respectively) but showed only a weak or no effect against other aggregating agents (ADP, adrenaline, collagen, serotonin, arachidonic acid).	Alprazolam	49-59	PCNA clamp associated factor	Homo sapiens	70-73	
8016392-11	1994	The PAF antagonist, alprazolam, increased gallbladder prostanoid production when administered alone and with LPS.	Alprazolam	20-30	PCNA clamp associated factor	Homo sapiens	4-7	
8383168-7	1993	In both cell types, triazolam and alprazolam, two PAF antagonists, and the calcium channel blocker verapamil inhibited PAF-induced calcium mobilization.	Alprazolam	34-44	PCNA clamp associated factor	Homo sapiens	119-122	
1325953-7	1992	The structurally dissimilar PAF receptor antagonists CV-6209 and alprazolam inhibited the CPAF-induced calcium changes at doses that competed with CPAF binding.	Alprazolam	65-75	PCNA clamp associated factor	Homo sapiens	28-31	
2519888-6	1989	In decreasing order of potency, the following PAF-acether antagonists inhibited the change in platelet cytosolic free calcium elicited by 10 nM PAF-acether: L-652,731, kadsurenone, triazolam, diltiazem and alprazolam.	Alprazolam	206-216	PCNA clamp associated factor	Homo sapiens	46-49	
2519888-6	1989	In decreasing order of potency, the following PAF-acether antagonists inhibited the change in platelet cytosolic free calcium elicited by 10 nM PAF-acether: L-652,731, kadsurenone, triazolam, diltiazem and alprazolam.	Alprazolam	206-216	PCNA clamp associated factor	Homo sapiens	144-147	
3579913-2	1987	The benzodiazepines alprazolam and triazolam, but not diazepam (1-10 microM), inhibit PAF induced aggregation but have no effect on aggregation induced by other platelet agonists such as ADP, epinephrine and collagen.	Alprazolam	20-30	PCNA clamp associated factor	Homo sapiens	86-89	
3579913-3	1987	The IC50 for aggregation by PAF (4 nM) in GFP is 1 microM for both alprazolam and triazolam.	Alprazolam	67-77	PCNA clamp associated factor	Homo sapiens	28-31	
3579913-7	1987	Alprazolam and triazolam, but not diazepam, caused competitive displacement of 3H-PAF from specific binding sites of GFP.	Alprazolam	0-10	PCNA clamp associated factor	Homo sapiens	82-85	
3579913-10	1987	These results are consistent with the interpretation that the specific inhibition of PAF induced platelet aggregation by alprazolam and triazolam, respectively, is due to competitive inhibition of binding of PAF to its receptor.	Alprazolam	121-131	PCNA clamp associated factor	Homo sapiens	85-88	
3579913-10	1987	These results are consistent with the interpretation that the specific inhibition of PAF induced platelet aggregation by alprazolam and triazolam, respectively, is due to competitive inhibition of binding of PAF to its receptor.	Alprazolam	121-131	PCNA clamp associated factor	Homo sapiens	208-211	
2893525-3	1987	We have found that the psychotropic triazolobenzodiazepine drugs, alprazolam and triazolam, potently (IC50 less than 1 microM) inhibit PAF-induced shape change, aggregation and secretion of human platelets.	Alprazolam	66-76	PCNA clamp associated factor	Homo sapiens	135-138	
3694533-3	1987	The negative inotropic effect of PAF was, however, antagonized by drugs known to inhibit PAF-induced platelet aggregation: the order of relative potency was SRI 63-441 greater than CV-3988 greater than alprazolam greater than or equal to triazolam; i.e., the same order in which these compounds antagonize the effects of PAF on platelets.	Alprazolam	202-212	PCNA clamp associated factor	Homo sapiens	33-36	
3694533-3	1987	The negative inotropic effect of PAF was, however, antagonized by drugs known to inhibit PAF-induced platelet aggregation: the order of relative potency was SRI 63-441 greater than CV-3988 greater than alprazolam greater than or equal to triazolam; i.e., the same order in which these compounds antagonize the effects of PAF on platelets.	Alprazolam	202-212	PCNA clamp associated factor	Homo sapiens	89-92	
3694533-3	1987	The negative inotropic effect of PAF was, however, antagonized by drugs known to inhibit PAF-induced platelet aggregation: the order of relative potency was SRI 63-441 greater than CV-3988 greater than alprazolam greater than or equal to triazolam; i.e., the same order in which these compounds antagonize the effects of PAF on platelets.	Alprazolam	202-212	PCNA clamp associated factor	Homo sapiens	89-92	
6150550-3	1984	It was found that in washed human platelets the psychotropic triazolobenzodiazepine drugs alprazolam and triazolam potently inhibited PAF-induced changes in shape, aggregation, and secretion.	Alprazolam	90-100	PCNA clamp associated factor	Homo sapiens	134-137